Deferred Income Tax Liabilities, Net in USD of Merck & Co., Inc. from Q4 2016 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.
Summary
Merck & Co., Inc. quarterly Deferred Income Tax Liabilities, Net history and change rate from Q4 2016 to Q3 2025.
  • Merck & Co., Inc. Deferred Income Tax Liabilities, Net for the quarter ending 30 Sep 2025 was $1.38B, a 59.8% increase year-over-year.
Deferred Income Tax Liabilities, Net, Quarterly (USD)
Deferred Income Tax Liabilities, Net, YoY Quarterly Change (%)

Merck & Co., Inc. Quarterly Deferred Income Tax Liabilities, Net (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.38B +$517M +59.8% 30 Sep 2025 10-Q 05 Nov 2025
Q2 2025 $1.43B +$551M +62.9% 30 Jun 2025 10-Q 05 Aug 2025
Q1 2025 $1.41B +$487M +52.8% 31 Mar 2025 10-Q 02 May 2025
Q4 2024 $1.39B +$516M +59.2% 31 Dec 2024 10-Q 05 Nov 2025
Q3 2024 $864M -$154M -15.1% 30 Sep 2024 10-Q 06 Nov 2024
Q2 2024 $876M -$120M -12% 30 Jun 2024 10-Q 05 Aug 2024
Q1 2024 $922M -$520M -36.1% 31 Mar 2024 10-Q 03 May 2024
Q4 2023 $871M -$924M -51.5% 31 Dec 2023 10-K 25 Feb 2025
Q3 2023 $1.02B -$1.4B -57.9% 30 Sep 2023 10-Q 03 Nov 2023
Q2 2023 $996M -$1.98B -66.5% 30 Jun 2023 10-Q 07 Aug 2023
Q1 2023 $1.44B -$1.63B -53% 31 Mar 2023 10-Q 05 May 2023
Q4 2022 $1.8B -$1.65B -47.8% 31 Dec 2022 10-K 26 Feb 2024
Q3 2022 $2.42B +$890M +58.3% 30 Sep 2022 10-Q 03 Nov 2022
Q2 2022 $2.97B +$1.49B +99.7% 30 Jun 2022 10-Q 05 Aug 2022
Q1 2022 $3.07B +$1.87B +155% 31 Mar 2022 10-Q 05 May 2022
Q4 2021 $3.44B +$2.44B +242% 31 Dec 2021 10-K 24 Feb 2023
Q3 2021 $1.53B -$250M -14.1% 30 Sep 2021 10-Q 05 Nov 2021
Q2 2021 $1.49B -$602M -28.8% 30 Jun 2021 10-Q 09 Aug 2021
Q1 2021 $1.2B -$739M -38% 31 Mar 2021 10-Q 05 May 2021
Q4 2020 $1.01B -$465M -31.6% 31 Dec 2020 10-K 25 Feb 2022
Q3 2020 $1.78B -$183M -9.34% 30 Sep 2020 10-Q 05 Nov 2020
Q2 2020 $2.09B +$2M +0.1% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $1.94B +$108M +5.89% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $1.47B -$232M -13.6% 31 Dec 2019 10-K 25 Feb 2021
Q3 2019 $1.96B -$105M -5.09% 30 Sep 2019 10-Q 05 Nov 2019
Q2 2019 $2.09B -$70M -3.24% 30 Jun 2019 10-Q 06 Aug 2019
Q1 2019 $1.84B -$371M -16.8% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $1.7B -$517M -23.3% 31 Dec 2018 10-K 26 Feb 2020
Q3 2018 $2.07B 30 Sep 2018 10-Q 06 Nov 2018
Q2 2018 $2.16B 30 Jun 2018 10-Q 07 Aug 2018
Q1 2018 $2.21B 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $2.22B -$2.86B -56.3% 31 Dec 2017 10-K 27 Feb 2019
Q4 2016 $5.08B 31 Dec 2016 10-K 27 Feb 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.